Pleural disease in patients with AIDS

Area of Science:

• Pulmonology
• Infectious Diseases
• Oncology

Background:

• Patients with Human Immunodeficiency Virus (HIV) are susceptible to various infectious and malignant pleuropulmonary disorders.
• AIDS-defining illnesses can manifest with pleural effusions, commonly caused by parapneumonic effusions/empyemas, tuberculosis, or Kaposi's sarcoma.
• The prevalence of these pleural complications varies geographically and between patient cohorts.

Purpose of the Study:

• To review the spectrum of pleuropulmonary complications in patients with Acquired Immunodeficiency Syndrome (AIDS).
• To discuss the common etiologies, clinical presentations, and management challenges of these conditions.
• To highlight the impact of evolving antiretroviral therapies on the incidence and presentation of AIDS-related pleural diseases.

Main Methods:

• Literature review of pleuropulmonary manifestations in HIV/AIDS patients.
• Analysis of common causes of pleural effusions, including infectious agents and malignancies.
• Discussion of the association between Pneumocystis carinii and spontaneous pneumothoraces in AIDS.

Main Results:

• Parapneumonic effusions/empyemas, tuberculosis, and Kaposi's sarcoma are the most frequent causes of AIDS-related pleural effusions.
• Pneumocystis carinii, while common in AIDS pulmonary disease, rarely causes pleural effusion but is linked to spontaneous pneumothoraces.
• Pleural complications in AIDS significantly contribute to morbidity and mortality.

Conclusions:

• Pleuropulmonary complications remain a significant concern in patients with HIV/AIDS.
• While antiretroviral therapy improves survival, it may lead to an increase in the prevalence of certain AIDS-related conditions, including pleural diseases.
• Effective management of these complications is crucial for improving outcomes in the AIDS population.